Evolent Health (Evolent Health) FCF Margin % : 14.99% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evolent Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Evolent Health's Free Cash Flow for the three months ended in Dec. 2023 was $83 Mil. Evolent Health's Revenue for the three months ended in Dec. 2023 was $556 Mil. Therefore, Evolent Health's FCF Margin % for the quarter that ended in Dec. 2023 was 14.99%.

As of today, Evolent Health's current FCF Yield % is 3.62%.

The historical rank and industry rank for Evolent Health's FCF Margin % or its related term are showing as below:

EVH' s FCF Margin % Range Over the Past 10 Years
Min: -25.79 Med: -9.6 Max: 5.8
Current: 5.8

During the past 11 years, the highest FCF Margin % of Evolent Health was 5.80%. The lowest was -25.79%. And the median was -9.60%.

EVH's FCF Margin % is ranked better than
65.32% of 666 companies
in the Healthcare Providers & Services industry
Industry Median: 1.415 vs EVH: 5.80

Evolent Health FCF Margin % Historical Data

The historical data trend for Evolent Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolent Health FCF Margin % Chart

Evolent Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-11.38

-4.94

1.52

-3.69

5.80

Evolent Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															6.52	-3.98	-1.32	10.51	14.99

Competitive Comparison of Evolent Health's FCF Margin %

For the Health Information Services subindustry, Evolent Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evolent Health's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Evolent Health's FCF Margin % falls into.

Evolent Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Evolent Health's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	113.837	/	1963.896
	=	5.80 %

Evolent Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	83.329	/	556.055
	=	14.99 %

Evolent Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Evolent Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolent Health (Evolent Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Evolent Health Inc (NYSE:EVH) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

9EH:Germany

Address

800 N. Glebe Road, Suite 500, Arlington, VA, USA, 22203

Website

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

Executives

Seth Blackley	officer: President	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Daniel Joseph Mccarthy	officer: PRESIDENT	800 N GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Emily Ann Rafferty	officer: Chief Operating Officer	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Toyin Ajayi	director	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Cheryl Scott	director	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Mary Bridget Duffy	director	C/O VOCERA COMMUNICATIONS, INC., 525 RACE STREET, SAN JOSE CA 95126
Diane Holder	director	800 GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Richard M Jelinek	director	40 W 47TH STREET, FLOOR 33, NEW YORK NY 10035
Frank J Williams	director, officer: Chief Executive Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
John Paul Johnson	officer: Chief Financial Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Jonathan Weinberg	officer: General Counsel	800 N. GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Steve Tutewohl	officer: Chief Operating Officer	800 NORTH GLEBE ROAD, SUITE 500, ARLINGTON VA 22203
Tunde Sotunde	director	800 N. GLEBE RD, SUITE 500, ARLINGTON VA 22203
Kim Keck	director	30 W. MONROE STREET, SUITE 1200, CHICAGO IL 60603
Craig A. Barbarosh	director	3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305